Summary: Clinical practice guidelines should never be the legal basis for determining whether or not patient harm was the result of negligence, and allowing use of guidelines only by a physician or facility to defend itself against a medical malpractice claim, and not by an injured patient to show negligence, is without any justification and is fundamentally unfair.
Recent discussions about national health care have included suggestions by some political leaders that doctors who practice “evidence-based medicine”1 or more specifically, follow “clinical practice guidelines” 2 (that may or may not stem from “evidence-based medicine”3), should be immune, or presumed to be immune, from lawsuits - even though a patient may have been injured or killed.
Both sides in malpractice litigation currently make limited use of clinical practice\ guidelines in settlement negotiations, or even to help lawyers decide whether or not to file suits.4 However, there are two major differences between this practice and recent proposals, both of which raise serious concerns about fairness and patient safety:
ONE-SIDED CLINICAL GUIDELINES AS LEGAL STANDARDS ARE UNFAIR AND RISK PATIENT SAFETY
THE PLETHORA OF OFTEN CONTRADICTORY GUIDELINES FOR THE SAME AREA OF MEDICAL PRACTICE RAISES SERIOUS QUESTIONS ABOUT THEIR USE AS LEGAL STANDARDS.
THE MEDICAL PROFESSION ITSELF HAS NOT ACCEPTED CLINICAL PRACTICE GUIDELINES AS APPROPRIATE LEGAL STANDARDS, EVEN FOR EXCULPATORY PURPOSES.
ONE-WAY USE OF GUIDELINES RAISES FUNDAMENTAL ISSUES OF FAIRNESS AND CONSTITUTIONALITY.
“[A]llowing such one-sided use of evidence in a court of law raises disturbing questions of fairness and of validity under the U.S. Constitution's Fifth and Fourteenth Amendments’ due process and equal protection mandates, and under state constitutional principles as well.”20
NOTES
1 Evidence-based medicine is “defined as the conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients.” Arnold J. Rosoff, “Evidence-Based Medicine and the Law: The Courts Confront Clinical Practice Guidelines,” Journal of Health Politics, Policy and Law, Vol. 26, No. 2, April 2001.
2 As defined by the Institute of Medicine, clinical practice guidelines are “systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances.” Andrew L. Hyams; 4 Jennifer A. Brandenburg; Stuart R. Lipsitz; David W. Shapiro; and Troyen A. Brennan; “Practice Guidelines and Malpractice Litigation: A Two-Way Street, Annals of Internal Medicince, 15 March 1995 | Volume 122 Issue 6 | Pages 450-455.
3 “EBM[evidence-based medicine] can show up in forms other than CPG[clinical practice guidelines]—for example, in journal articles, unpublished studies, and expert testimony. Conversely, CPGs are not necessarily based upon EBM—although
the vast majority of the CPGs being generated nowadays are, or at least purport to be. Cynthia Mulrow and Kathleen Lohr's essay recognizes that guidelines generated primarily through a professional consensus process—the traditional approach— may differ from those based more directly on hard, empirical evidence—the EBM approach.” Arnold J. Rosoff, “Evidence-Based Medicine and the Law: The Courts Confront Clinical Practice Guidelines,” Journal of Health Politics, Policy and Law, Vol. 26, No. 2, April 2001.
4 Andrew L. Hyams; Jennifer A. Brandenburg; Stuart R. Lipsitz; David W. Shapiro; and Troyen A. Brennan; “Practice Guidelines and Malpractice Litigation: A Two-Way Street, Annals of Internal Medicince, 15 March 1995 | Volume 122 Issue
6 | Pages 450-455.
5 Arnold J. Rosoff, “Evidence-Based Medicine and the Law: The Courts Confront Clinical Practice Guidelines,” Journal of Health Politics, Policy and Law, Vol. 26, No. 2, April 2001.
6 George J. Annas, J.D., M.P.H., “The Patient’s Right to Safety – Improving the Quality of Care through Litigation against Hospitals,” New England Journal of Medicine, May 11, 2006.
7 Arnold J. Rosoff, “Evidence-Based Medicine and the Law: The Courts Confront Clinical Practice Guidelines,” Journal of Health Politics, Policy and Law, Vol. 26, No. 2, April 2001.
8 Ibid.
9 Ibid.
10 “Developing Trusted Clinical Practice Guidelines, Selected Findings from Knowing What Works in Health Care: A Roadmap for the Nation,” Institute of Medicine, January 2008.
11 See, e.g., ACOG News Release, Mark 25, 2005 http://www.acog.org/from_home/publications/press_releases/nr03-15-
05.cfm; Help Your Patients Push for Medical Liability Reform,
http://www.acog.org/departments/dept_notice.cfm?recno=11&bulletin=3933
12 “A new and rapidly growing specialty society coalition called Doctors for Medical Liability Reform is poised to wrest the helm of the tort reform campaign from the American Medical Association. With $10 million in its coffers so far, Doctors for Medical Liability Reform (DMLR) plans an aggressive television campaign during the 2004 election season with one goal in mind: to change the balance of power in the U.S. Senate to guarantee passage of a federal medical liability reform bill. Other
$1-million donors are the American Association of Neurological Surgeons/Congress of Neurological Surgeons, the American College of Emergency Physicians, the American College of Surgeons, and the American Academy of Orthopaedic Surgeons. The American College of Cardiology pledged $500,000, and the North American Spine Society pledged $100,000, according to Dr. Dunsker.…[T]the American College of Obstetricians and Gynecologists and the American Academy of Dermatology had also joined the new coalition and agreed to donate undisclosed amounts. Peggy Peck, “Coalition includes ACOG: specialty societies push tort reform, OB/GYN News, March 1, 2004.
13 Andrew L. Hyams; Jennifer A. Brandenburg; Stuart R. Lipsitz; David W. Shapiro; and Troyen A. Brennan; “Practice Guidelines and Malpractice Litigation: A Two-Way Street, Annals of Internal Medicince, 15 March 1995 | Volume 122 Issue
6 | Pages 450-455.
14 Arnold J. Rosoff, “Evidence-Based Medicine and the Law: The Courts Confront Clinical Practice Guidelines,” Journal of Health Politics, Policy and Law, Vol. 26, No. 2, April 2001.
15 Ibid.
16 Ibid.
17 Ibid., citing (American Medical Association 1993: 58; Hirshfeld 1993: 323)(“As Richard F. Corlin, M.D., testified on behalf of the AMA (1993: 58): ‘At the present time, insufficient evidence exists to show that clinical practice guidelines
can be developed in a manner specific enough to be introduced as an affirmative defense in medical liability litigation.’ It is notable that the AMA's reservation about CPGs was stated even in the context of their defensive use.”
18 Linda L. LeCraw, Esq., “Use of Clinical Practice Guidelines in Medical Malpractice Litigation,” Journal of Oncology
Practice, Vol 3, No 5 (September), 2007.
19 Ibid.
20 Ibid.